KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...

While mRNA vaccines trigger potent initial immune responses, emerging data suggest they do not generate durable plasma cells, ...

The 5th mRNA-Based Therapeutics Summit Europe is the leading European industry-focused forum dedicated to accelerating the ...

A new preclinical study shows that mRNA delivered through lipid nanoparticles can trigger local antibody production in muscle ...

To accurately gauge a vaccine’s risks, it is also crucial to compare its side effects with the effects of the illness it ...

Researchers found that using mental models—visual, verbal, or animated—helps people understand mRNA vaccination science, counter misconceptions, and reduce misinformation spread.

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the blueprint for functional ...

A new approach has been proposed to suppress the side effects of messenger ribonucleic acid (mRNA), opening up possibilities ...

CDMOs have become structural pillars of drug development, keeping pipelines moving, absorbing operational shocks, and turning ...

An internal memo written by the Food and Drug Administration’s top vaccine regulator offers a concerning glimpse into the ...